From Decoupling To Delisting: Might Biden-Xi Talks Ease Biotech Overhang?

While a two-hour-plus online discussion between the leaders of the world's two largest economies had some encouraging signs for the biopharma sector, more remains to be done and multiple other factors are playing into a mix of decoupling pressures.